Clover Health (CLOV) reported significant growth with a 48% year-over-year increase in Medicare Advantage membership, 56% revenue growth, and 54% gross profit growth. This performance is driven by cohort maturation and the Clover Assistant platform. The company's valuation remains attractive, trading at a 78% discount to the sector median EV/sales, with potential upside if profitability per member and SaaS revenue continue to improve. Key risks include member retention, claims inflation, regulatory changes, and scaling challenges for its SaaS business, Counterpart Health.
Yvonne Wassenaar, a director at Rubrik, sold 721 shares at a price of $75 each just before the company's stock experienced a significant rally. This sale occurred ahead of the stock's upward movement, which may be of interest to investors tracking in...
Digi Power X reported $6.6 million in revenue for Q2 2026, including its first AI compute revenue of about $1.1 million from GPU rentals. The company invested $30 million in GPU infrastructure and achieved positive adjusted EBITDA of $3.3 million. Co...
Replenish Nutrients Holding Corp received its first monthly payment of $104,508 under a $1.95 million financing agreement with Sorbie Bornholm LP. This payment is the first of 24 monthly settlements starting August 11, 2026, based on a formula tied t...
The official Shiba Inu (SHIB) X account exhibited unusual behavior by following a low-cap meme coin and posting a comment, prompting community concerns of a possible hack or security breach. A prominent community member warned investors to treat any ...
Ethereum's tokenization of real-world assets (RWA) has grown to over $17 billion, with a 0.5% increase in Distributed Asset Value over the past 30 days. This growth has driven a nearly 5% rise in RWA holders and an 18% increase in transfer volume, co...
